|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Delcath Systems, Inc.
| | | Phone: | (212) 489-2100 | Fax: | (212) 489-2102 | Year Established: | 1988 | Ticker: | DCTH | Exchange: | OTCQB | Main Contact: | John Purpura, Executive VP, Operations | | Other Contacts: | Barbra C. Keck, CFO Jennifer Simpson, PhD., M.S.N., C.R.N.P., President & CEO
| | Company Description | Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology. Their proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. | |
|
|
|
|
|